# Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

> **NCT00791570** · PHASE1 · COMPLETED · sponsor: **Osaka University** · enrollment: 17 (actual)

## Conditions studied

- Neovascular Maculopathy
- Age Related Macular Degeneration

## Interventions

- **BIOLOGICAL:** VEGFR1 and VEGFR2

## Key facts

- **NCT ID:** NCT00791570
- **Lead sponsor:** Osaka University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2012-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791570

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791570, "Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00791570. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*